Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting
Daniele Di Carlo(Istituto Pasteur), Ombretta Turriziani(Sapienza University of Rome), Luigi Celani(Sapienza University of Rome), Caterina Fimiani(Policlinico Umberto I), Francesco Maria Di Campli, Ivano Mezzaroma(Istituto Superiore di Sanità), Enrico Palermo(Istituto Pasteur), Francesca Falasca(Sapienza University of Rome), Guido Antonelli(Policlinico Umberto I), Guido Siccardi(S.P.E.C.I.E.S.), Gabriella d’Ettorre(Policlinico Umberto I)
Cited by 11
Related Papers
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
|Frontiers in Medicine|2020|218
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
|Nutrients|2020|205
Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge
|Journal of General Internal Medicine|2021|159
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
|BMC Infectious Diseases|2017|152